DE69402058T2 - Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen - Google Patents

Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen

Info

Publication number
DE69402058T2
DE69402058T2 DE69402058T DE69402058T DE69402058T2 DE 69402058 T2 DE69402058 T2 DE 69402058T2 DE 69402058 T DE69402058 T DE 69402058T DE 69402058 T DE69402058 T DE 69402058T DE 69402058 T2 DE69402058 T2 DE 69402058T2
Authority
DE
Germany
Prior art keywords
pct
optionally
derivatives
optionally substituted
perhydroisoindol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69402058T
Other languages
English (en)
Other versions
DE69402058D1 (de
Inventor
Andre Crespo
Veronique Fardin
Jean-Marc Guillaume
Jean-Luc Malleron
Jean-Francois Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of DE69402058D1 publication Critical patent/DE69402058D1/de
Publication of DE69402058T2 publication Critical patent/DE69402058T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DE69402058T 1993-04-05 1994-04-01 Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen Expired - Fee Related DE69402058T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9303965A FR2703679B1 (fr) 1993-04-05 1993-04-05 Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR1994/000371 WO1994022822A1 (fr) 1993-04-05 1994-04-01 Derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69402058D1 DE69402058D1 (de) 1997-04-17
DE69402058T2 true DE69402058T2 (de) 1997-09-18

Family

ID=9445733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69402058T Expired - Fee Related DE69402058T2 (de) 1993-04-05 1994-04-01 Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen

Country Status (21)

Country Link
US (1) US5631279A (de)
EP (1) EP0693059B1 (de)
JP (1) JPH08508283A (de)
KR (1) KR960701842A (de)
AT (1) ATE150014T1 (de)
AU (1) AU6506894A (de)
CA (1) CA2158663A1 (de)
CZ (1) CZ258495A3 (de)
DE (1) DE69402058T2 (de)
DK (1) DK0693059T3 (de)
ES (1) ES2099601T3 (de)
FI (1) FI954730A (de)
FR (1) FR2703679B1 (de)
GR (1) GR3022798T3 (de)
HU (1) HUT74089A (de)
IL (1) IL109217A0 (de)
NO (1) NO953913L (de)
PL (1) PL310948A1 (de)
SK (1) SK123595A3 (de)
TW (1) TW333525B (de)
WO (1) WO1994022822A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
FR2737495B1 (fr) * 1995-08-02 1997-08-29 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use
DE102006007882A1 (de) 2006-02-21 2007-08-30 Bayer Cropscience Ag Cycloalkyl-phenylsubstituierte cyclische Ketoenole
AU2012372019B2 (en) * 2011-12-22 2017-06-15 Connexios Life Sciences Pvt. Ltd. Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6372689A (ja) * 1986-09-16 1988-04-02 Taisho Pharmaceut Co Ltd （−）−α−カイニン酸の中間体およびその製造方法
FR2654725B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2654726B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone et leur preparation.
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2676443B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole et leur preparation.
FR2689889B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, et leur preparation.
FR2689888B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
IL109217A0 (en) 1994-07-31
FI954730A0 (fi) 1995-10-04
WO1994022822A1 (fr) 1994-10-13
CZ258495A3 (en) 1996-01-17
KR960701842A (ko) 1996-03-28
ES2099601T3 (es) 1997-05-16
TW333525B (en) 1998-06-11
EP0693059B1 (de) 1997-03-12
HUT74089A (en) 1996-11-28
DK0693059T3 (da) 1997-09-15
HU9502902D0 (en) 1995-11-28
EP0693059A1 (de) 1996-01-24
FI954730A (fi) 1995-11-17
PL310948A1 (en) 1996-01-08
AU6506894A (en) 1994-10-24
ATE150014T1 (de) 1997-03-15
JPH08508283A (ja) 1996-09-03
FR2703679B1 (fr) 1995-06-23
NO953913D0 (no) 1995-10-02
US5631279A (en) 1997-05-20
CA2158663A1 (fr) 1994-10-13
GR3022798T3 (en) 1997-06-30
FR2703679A1 (fr) 1994-10-14
SK123595A3 (en) 1996-06-05
DE69402058D1 (de) 1997-04-17
NO953913L (no) 1995-10-02

Similar Documents

Publication Publication Date Title
FI944729A (fi) Perhydroisoindolijohdannaiset substanssi P:n antagonisteina
DE69209290D1 (de) Perhydroisoindolderivate, ihre herstellung und diese enthaltende arzneimittel
TW365603B (en) Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
DE69505542D1 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
DE69402058D1 (de) Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen
NO973241L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee